Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (101-110 of 203) with videos related to

Pageof 21
Sort By:
Comparative Medicine|November 12, 2013
Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta)Cynthia M McCully, Devang Pastakia, John Bacher, et al.
Pediatric Blood & Cancer|September 11, 2019
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)Julia W Cohen, Brigitte C Widemann, Joanne Derdak, et al.
Pediatric Research|August 28, 2024
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatmentKathryn M Lemberg, Andrea M Gross, Lauren M Sproule, et al.
Cancers|January 25, 2025
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of SelumetinibMillicent S Curlee, Mary Anne Toledo-Tamula, Melissa Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Journal of the National Cancer Institute|March 11, 2026
Rare cancers research: Current state of knowledge and emerging opportunities for prevention and interceptionKajal Biswas, Sagar Ghosh, Payal P Khincha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinomaElizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Neuro-Oncology|August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromasRegina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Pediatric Blood & Cancer|September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromasAeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Pageof 21

Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
Comparative Medicine|November 12, 2013
Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta)Cynthia M McCully, Devang Pastakia, John Bacher, et al.
Pediatric Blood & Cancer|September 11, 2019
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)Julia W Cohen, Brigitte C Widemann, Joanne Derdak, et al.
Pediatric Research|August 28, 2024
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatmentKathryn M Lemberg, Andrea M Gross, Lauren M Sproule, et al.
Cancers|January 25, 2025
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of SelumetinibMillicent S Curlee, Mary Anne Toledo-Tamula, Melissa Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.
Journal of the National Cancer Institute|March 11, 2026
Rare cancers research: Current state of knowledge and emerging opportunities for prevention and interceptionKajal Biswas, Sagar Ghosh, Payal P Khincha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinomaElizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.
Neuro-Oncology|August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromasRegina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Pediatric Blood & Cancer|September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromasAeRang Kim, Eva Dombi, Kathleen Tepas, et al.
Pageof 21